Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction.
about
Impact of a critical pathway on acute myocardial infarction quality indicatorsCritical pathways in the emergency department improve treatment modalities for patients with ST-elevation myocardial infarction in a European hospitalA review of interventions and system changes to improve time to reperfusion for ST-segment elevation myocardial infarctionContemporary evidence: baseline data from the D2B Alliance.Factors Contributing to Door-to-Balloon Times of ≤90 Minutes in 97% of Patients with ST-Elevation Myocardial Infarction: Our One-Year Experience with a Heart Alert Protocol.Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study.Quality improvement implementation and hospital performance on quality indicators.The door-to-balloon alliance for quality: who joins national collaborative efforts and why?Spectrum of reperfusion strategies and factors influencing the use of primary angioplasty in patients with acute myocardial infarction admitted to hospitals with the facilities to perform primary angioplasty. Maximal Individual Therapy in Acute MyocIn-hospital time to treatment of patients with acute ST elevation myocardial infarction treated with primary angioplasty: determinants and outcome. Results from the registry of percutaneous coronary interventions in acute myocardial infarction of thPotential generation of geographical inequities by the introduction of primary percutaneous coronary intervention for the management of ST segment elevation myocardial infarction.Relationship between organizational factors and performance among pay-for-performance hospitalsEstablishing primary angioplasty as the preferred treatment for acute myocardial infarction.
P2860
Q28167564-CE929838-CD69-4491-953B-BDEC17197964Q28212503-A107E5F8-C6C2-4DE2-953E-19FF8A99769DQ30483125-2510E541-6A8B-45F2-B745-FB9D2E643213Q31172346-10701B6F-D992-41CA-AE81-7B31B36F7872Q34121034-632D119A-9B84-4B99-8040-AAD4F965309AQ35165758-B75EE4B5-31CA-4133-88DC-91D66E9FA7D0Q35225588-550075E4-8565-455C-A645-0EE1B0B1FFAAQ35473095-85223A68-95F9-4301-86C5-02EC30CC2222Q35565924-2DA83092-650B-48D2-8086-9DC55ECF011FQ35584496-77A76E5C-A3B0-4816-9807-2216AED64253Q36166190-3F64B17C-C215-4251-A0F0-2798CDA4C04DQ37225232-B91E351F-201D-4A82-9DFA-05A679B1D045Q52115521-738B855B-BF77-4C47-B1A3-CC95DB90DD8F
P2860
Effect of continuous quality improvement analysis on the delivery of primary percutaneous transluminal coronary angioplasty for acute myocardial infarction.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Effect of continuous quality i ...... r acute myocardial infarction.
@en
Effect of continuous quality i ...... r acute myocardial infarction.
@nl
type
label
Effect of continuous quality i ...... r acute myocardial infarction.
@en
Effect of continuous quality i ...... r acute myocardial infarction.
@nl
prefLabel
Effect of continuous quality i ...... r acute myocardial infarction.
@en
Effect of continuous quality i ...... r acute myocardial infarction.
@nl
P2093
P1476
Effect of continuous quality i ...... r acute myocardial infarction.
@en
P2093
Carrozza JP
P304
P356
10.1016/S0002-9149(97)00074-X
P407
P50
P577
1997-05-01T00:00:00Z